The effects of triiodothyronine augmentation on antithrombin III levels in sepsis

American Surgeon

Volumn 67, Issue 3, 2001, Pages 253-255

  Chapital, Alyssa D ^a   Hendrick, Steven R ^a   Lloyd, Larry ^a   Pieper, David ^a  

^a ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; LIOTHYRONINE;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; BLOOD; DISEASE MODEL; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFECT; DRUG MONITORING; DRUG SCREENING; EUTHYROID SICK SYNDROME; METABOLISM; MICROBIOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; RANDOMIZATION; RAT; SEPSIS; SPRAGUE DAWLEY RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANTITHROMBIN III; DISEASE MODELS, ANIMAL; DISSEMINATED INTRAVASCULAR COAGULATION; DRUG EVALUATION, PRECLINICAL; DRUG MONITORING; EUTHYROID SICK SYNDROMES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS; TRIIODOTHYRONINE;

EID: 0035286475     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Mammen EF. The hematologic manifestations of sepsis. J Antimicrob Chemother 1998;41:17-24.
2. Fourrier F, Chopin C. Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest 1993;104:882-8.
3. Wilson RF, Mammen EF, Tyburski JG. Antithrombin levels related to infections and outcome. J Trauma 1996;40:384-7.
4. Wartofsky L, Burman KD. Alterations in thyroid function in patients with systemic illness: The "euthyroid sick syndrome." Endocr Rev 1982;3:164-217.
5. Dulchavsky SA, Hendrick SR, Dutta S. Pulmonary biophysical effects of triiodothyronine augmentation during sepsis-induced hypothyroidism. J Trauma 1993;35:104-9.
6. Eisele B, Lamy M, Thijs LG, et al. Antithrombin III in patients with severe sepsis: A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis. Intensive Care Med 1998;24:663-72.